Vaxart
VXRT
$0.69
Share price
-7.30%
Change (1 day)
-16.35%
Change (1 year)
Categories
Vaxart (VXRT) - P/B ratio
P/B ratio as of May 2024 : 2.25
According to Vaxart's latest financial reports the company has a price-to-book ratio of 2.25.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Vaxart - P/B ratio (from 2001 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 1.51 | 32.12% |
| 2022-12-31 | 1.14 | -72.82% |
| 2021-12-31 | 4.20 | -17.16% |
| 2020-12-31 | 5.07 | 287.89% |
| 2019-12-31 | 1.31 | 9.31% |
| 2018-12-31 | 1.19 | -41.05% |
| 2017-12-31 | 2.03 | 19.39% |
| 2016-12-31 | 1.70 | 30.21% |
| 2015-12-31 | 1.30 | 36.61% |
| 2014-12-31 | 0.9542 | -48.45% |
| 2013-12-31 | 1.85 | 29.21% |
| 2012-12-31 | 1.43 | 4.61% |
| 2011-12-31 | 1.37 | -66.3% |
| 2010-12-31 | 4.06 | 62.04% |
| 2009-12-31 | 2.51 | 74.94% |
| 2008-12-31 | 1.43 | 3.33% |
| 2007-12-31 | 1.39 | -62.44% |
| 2006-12-31 | 3.69 | 197.12% |
| 2005-12-31 | 1.24 | -58.85% |
| 2004-12-31 | 3.02 | 33.32% |
| 2003-12-31 | 2.27 | 79.14% |
| 2002-12-31 | 1.26 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | -6.34 | -381.63% | Bahamas |
 NRC Health
NRC | 17.1 | 656.93% | 🇺🇸 USA |